WNK2 and renal carcinoma: Hydroxycoumarin might be a useful adjuvant for melanoma therapy because of its selective anti-proliferative agents that mediate apoptosis in renal carcinoma cells, through modulation of mitogen-activated protein kinases attributed to a nitro group in the aromatic ring (Kostova, 2005; Jung and Oh, 2011).